Massachusetts Biotech Rebounds as Investment Returns After Years of Industry Turmoil
Massachusetts’ powerful biotechnology industry is showing signs of a significant comeback in 2026 after several difficult years marked by layoffs, falling investment, empty laboratory buildings and uncertainty over federal scientific funding. New data from the Massachusetts Biotechnology Council, or MassBio, suggests capital is returning rapidly, even though employment has not yet recovered from the downturn. […]
